Drug policy + evidence operations · Independent research
Drug Market Transition Evidence Lab
Live source-anchored policy assessment workbench · v2 August 2026
Turn an individual policy or market development into a reviewable evidence record instead of implying that an unstaffed archive is continuously monitoring a whole sector.
Controlled visual demonstration
Current live interface
This sandboxed preview shows the current public interface. Open the full site to use the build in its intended window.
What I noticed
A policy announcement is not a market outcome. Transition claims can look successful while health, rights, participation, ownership, Indigenous authority, or environmental consequences remain unknown, mixed, or adverse.
What I researched
The v2 framework draws on Transform Drug Policy Foundation's practical regulation guides, UNDP's 2025 Development Dimensions of Drug Policy, and the UNODC World Drug Report 2026 data architecture. The original seven-part research demonstration is preserved as a clearly dated July 27, 2026 archive.
What exists
A source-anchored evidence-record builder with six assessment dimensions—public health, human rights, equity and participation, market power, Indigenous rights, and development and environment. Users classify each dimension as unknown, toward, mixed, or away; add evidence notes; receive a deterministic synthesis; export Markdown; print to PDF; route to primary sources; and inspect the preserved research archive.
Who it serves
Policy researchers, advocates, regulators, funders, journalists, and institutional teams examining whether a drug-market transition is producing public-interest outcomes.
What it demonstrates
Policy framework operationalization, evidence-state design, transparent synthesis logic, research preservation, and truth-aware product architecture.
Current evidence
Production deployment and canonical routes were verified after rebuild. The tool does not claim automated monitoring, causal proof, or continuing accuracy of the archived research. Each new record requires a source date, primary URL or identifier, and dimension-level evidence notes; unknown remains a valid result. It is informational and not legal, medical, or policy advice.
Verified build record
What is actually running, and what it is not.
LiveLive · v2, August 2026
The problem. Drug-policy transitions are argued from whichever dimension the arguer cares about — health, or crime, or revenue — and the dimensions that were not measured quietly become the ones that did not matter.
What it does. Builds a source-anchored evidence record across six dimensions for a given drug-policy or regulatory transition, so a claim about one dimension can be read against what is and is not documented in the others.
Built on. A Next.js application on Vercel.
What it does not establish. It organises published evidence. It does not generate findings, and an absence of evidence in a dimension is recorded as an absence rather than as a null result.
This record is generated from the same inventory as the complete build index: the production URL was checked at the last regeneration, and the status line above repeats what the build reports about itself rather than restating an intention.